A new study suggests that healthcare providers need to discuss aspirin use with elderly patients and discuss with them all the risks and benefits of continued aspirin treatment to prevent cardiovascular disease.
The cross-sectional study by researchers from Johns Hopkins, Ohio State University, and King Saud University was designed to determine the prevalence of U.S. adults aged 70 or older with and without diabetes using aspirin for the primary and secondary prevention of cardiovascular disease. Use diseases. The researchers looked at the age, gender, and CVD risk category of the patients.
The study found that older adults with diabetes were more likely to use preventive aspirin than older adults without diabetes. However, the results suggest that 9.9 million older US adults who previously took aspirin for primary prevention are not recommended for continued use, particularly in diabetics, the authors said.
This guide stems in part from the fact that aspirin can make the risk of bleeding worse, and people with diabetes who are already at an increased risk of bleeding compared to those without diabetes.
Ultimately, the researchers believe that future studies should investigate the impact of guideline updates on clinician behavior and the relationship between changing trends in preventive aspirin use and the development of CVD in older adults.
Subjects:
Aspirin cardiovascular disease diabetes
